Library Home | Reset filters
Select one or more filter options and click search below.
Reset filters
AUTHOR(S) Liang-Jen Wang; Kuang-Che Kou; Kuo-Shu Tang (et al.)
AUTHOR(S) Cassandra Pingali; Fan Zhang; Tammy A. Santibanez (et al.)
Although COVID-19–associated illness is generally mild in adolescents, they can experience severe health outcomes, including hospitalization and death.1 COVID-19 vaccinations are effective for preventing serious COVID-19–associated illness in adolescents.1 The Advisory Committee on Immunization Practices (ACIP) recommends persons aged 6 months or older receive COVID-19 vaccination.2 As of April 14, 2022, among US individuals aged 12 to 17 years, COVID-19 vaccination coverage (≥1 dose) was 68%,3 lower than for other vaccines routinely recommended for adolescents.4 The ACIP recommends adolescents aged 11 to 12 years receive tetanus, diphtheria, and acellular pertussis (Tdap), meningococcal conjugate (MenACWY), and human papillomavirus (HPV) vaccinations.2 This cross-sectional study investigated associations between routine adolescent vaccination status and parental intent or hesitancy to get a COVID-19 vaccine for their adolescent. The National Immunization Survey–Child COVID Module (NIS-CCM) is a national telephone survey of households with children or adolescents aged 6 months to 17 years used to measure parent-reported COVID-19 vaccination coverage and intent to vaccinate their child.5 The NIS-CCM uses the NIS-Child sampling frame; for adolescents aged 13 to 17 years, it follows the NIS-Teen interview, allowing for analysis of both routine (HPV, MenACWY, and Tdap) and COVID-19 vaccination coverage.5 NIS-CCM interviews from July 22, 2021, through February 26, 2022, were analyzed. Survey respondents were those self-reporting being most knowledgeable about the child’s vaccinations (hereafter, parent). Vaccination status was based on parental report. Data were weighted to represent the noninstitutionalized population of US adolescents and calibrated to administered vaccinations data.3 Analyses were performed using SAS, version 9.4
AUTHOR(S) Steward Mudenda; Moses Mukosha; Brian Godman (et al.)
AUTHOR(S) Kazım Baş; Nazan Gürarslan Baş
AUTHOR(S) Yundi Ma; Jingjing Ren; Yang Zheng (et al.)
To evaluate Chinese parents' willingness to vaccinate their children against COVID-19, identify its predictors, and provide a reference for raising the COVID-19 vaccination rate for children. PubMed, Cochrane Library, Embase, and the databases in Chinese, including CNKI, WanFang, VIP, CBM, were searched from December 2019 to June 2022, and citation tracking was used to identify relevant studies. To calculate the rate with 95% confidence intervals (CI), a random-effects model was used. To explore sources of heterogeneity, sensitivity analysis and subgroup analysis were conducted. This analysis was registered on PROSPERO (CRD42022346866) and reported in compliance with the PRISMA guidelines.
AUTHOR(S) Esra' O. Taybeh; Rawan Alsharedeh; Shereen Hamadneh
This study aimed to explore perceptions and willingness to get coronavirus disease 2019 (COVID-19) booster vaccination among pregnant and lactating women in Jordan. A cross-sectional study using a 29-item web-based questionnaire was conducted. Sociodemographic characteristics, vaccine acceptance, confidence in the booster dose of COVID-19 vaccine, perception of risk for COVID-19, and acceptance to participate in COVID-19 booster vaccine clinical trials were prospectively evaluated. Logistic regression was used to identify factors that might affect the participants’ acceptance of a COVID-19 vaccine and their willingness to enroll in clinical trials of a booster dose of COVID-19 vaccine.
AUTHOR(S) Aicha Bourguiba; Shahd AbuHijleh; Yasmin Nached
AUTHOR(S) Fabiano Elisei Serra; Elias Ribeiro Rosa Junior; Patricia de Rossi (et al.)
AUTHOR(S) Harriet Itiakorit; Abhilash Sathyamoorthi; Brigid E. O’Brien (et al.)
AUTHOR(S) Serine Ramlawi; Katherine A. Muldoon; Sandra I. Dunn (et al.)
COVID-19 vaccines are recommended for pregnant and lactating individuals, and there is substantial evidence for their safety and effectiveness. As the pandemic continues, information on worries and beliefs surrounding perinatal COVID-19 vaccination remains important to inform efforts aimed at improving vaccine uptake. Our objectives were to assess factors associated with COVID-19 vaccination among perinatal individuals; and to explore motivational factors associated with willingness to be vaccinated among unvaccinated perinatal individuals. This was a cross-sectional web-based survey of preconception, pregnant, and lactating individuals in Canada. The outcomes of interest were vaccination with at least one dose of any COVID-19 vaccine and willingness to be vaccinated among unvaccinated individuals. Sample characteristics were summarized using frequencies and percentages. The association between eight prespecified risk factors and two outcomes (vaccination status and willingness to be vaccinated) was assessed by logistic regression. Odds ratios (OR) and 95% confidence intervals (CI) were calculated for the total sample, and across perinatal sub-groups.
AUTHOR(S) Courtney A. Gidengil; Andrew M. Parker; Amber M. Gedlinske (et al.)
AUTHOR(S) Ali Al-kassab-Córdova; Claudia Silva-Perez; Carolina Mendez-Guerra (et al.)
To identify the associated factors and assess the inequalities of full vaccination coverage (FVC) among Peruvian infants aged 12–23 months during the COVID-19 pandemic in a nationally representative sample. This study carried out a population-based cross-sectional study based on a secondary data analysis using the 2021 Peruvian Demographic Health Survey (DHS) in infants aged 12 to 23 months. The sampling design was probabilistic, multistage, stratified, and independent at both departmental and area of residence levels. FVC was defined according to the WHO definition. It performed generalized linear models (GLM) Poisson family log link function to estimate crude (aPR) and adjusted prevalence ratios (aPR). Also, for inequality assessment, we calculated the concentration curve (CC), concentration index (CI), and Erreygers normalized concentration index (ECI).
AUTHOR(S) Shuning Tang; Xin Liu; Yingnan Jia (et al.)
AUTHOR(S) Zhihao Wang; Xiqin Fang; Tao Han (et al.)
This study aimed to investigate the effects of the coronavirus disease 2019 4 (COVID-19) vaccine on epileptic seizures, as well as its adverse effects, in children with epilepsy (< 18 years). This anonymous questionnaire study involved a multicenter prospective survey of outpatients and inpatients with epilepsy (<18 years) registered in epilepsy clinics in 8 hospitals in six cities of Shandong Province.
AUTHOR(S) P. G. Szilagyi; M. D. Shah; J. R. Delgado (et al.)
This study aimed to assess the likelihood of US parents to have their children receive a pediatric coronavirus disease 2019 (COVID-19) vaccine and to understand parental concerns about the vaccines. Study participants were selected from The Understanding America Study (UAS), a nationally-representative online panel who were surveyed between February 17, 2021 and March 30, 2021. This was a survey-based study. Parents were asked about intent to have their child vaccinated against COVID-19, their perceptions about the vaccine, their own likelihood of getting a COVID-19 vaccine, whether their child previously received the flu vaccine, their trust in sources of information about a COVID-19 vaccine, and their trust in the vaccine development and approval process. Descriptive and multivariate analyses were used to assess likelihood of vaccination and to understand the association between likelihood of child vaccination and parent demographics, child age, and parental perceptions about COVID-19 vaccines.
UNICEF Innocenti's Children and COVID-19 Library is a database collecting research from around the world on COVID-19 and its impacts on children and adolescents.
Subscribe to updates on new research about COVID-19 & children
Check our quarterly thematic digests on children and COVID-19
COVID-19 & Children: Rapid Research Response